United Kingdom· GB-APID-7323411000001109
Dacarbazine 100mg powder for solution for injection vials
A dacarbazine product containing dacarbazine, registered in United Kingdom by medac UK. The same ATC class is registered in 15 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Dacarbazine is registered in 15 of 19 countries.
Countries holding a registration under ATC L01AX04 (dacarbazine), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Dacarbazine · ATC L01AX04
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of dacarbazine costs, country by country.
Normalised to the WHO defined daily dose (43.3 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Dacarbazine · price per daily dose (43.3 mg)
USD · FX 28 Sept 2026
- CH Switzerland$5.12
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Dacarbazine
- Manufacturer
- medac UK
- Country
- United Kingdom (GB)
- ATC code
- L01AX04
- ATC class
- Dacarbazine
- Defined daily dose
- 43.3 mg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin4037353333222
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
237 interactions on record for dacarbazine.
Graded by severity as the source publishes them — 35 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dacarbazine · interactions on record
237 records
- 35 severe
- 114 moderate
- 14 minor
- 74 info
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- Nalidixic acidJ01MB02severe
- CladribineL01BB04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dacarbazine in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandDacarbazine Iwa ConsultingIWA Consulting ApS
- FranceDACARBAZINE LIPOMED 100 mg, poudre pour solution injectable ou perfusionLIPOMED (ALLEMAGNE)
- BelgiumDacarbazine Accord 1000 mgAccord Healthcare
- IrelandDacarbazine Lipomed 1000 mg powder for solution for infusionLipomed GmbH
- SpainDACARBAZINA ACCORD 1 000 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFGAccord Healthcare S.L.U.
- United StatesDacarbazineFresenius Kabi USA, LLC
- NorwayDacarbazineMedac GmbH
- PolandDetimedac 100 mgmedac Gesellschaft fuer klinische Spezialpraeparate mbH
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Austria · Dacarbazin Lipomed, Dacarbazine Medac
- Belgium · Dacarbazine, Dacarbazine Medac
- Cyprus · Dacarbazine Lipomed
- Czechia · Dacarbazine Medac
- Germany · Dacarbazin Lipomed, Detimedac
- Denmark · Dacarbazine Lipomed, Dacarbazine Medac
- Spain · Dacarbazina Accord, Dacarbazina Medac
- Finland · Dacarbazine Lipomed, Dacarbazine Medac
- France · Dacarbazine Accord, Dacarbazine Lipomed
- Hungary · Dacarbazine Accord, Dacarbazine Lipomed
- Ireland · Dacarbazine Lipomed, Dacarbazine Medac
- Italy · Dacarbazina Lipomed, Dacarbazina Medac
- Netherlands · Dacarbazine Medac
- Norway · Dacarbazine Lipomed
- Poland · Detimedac
- Portugal · Dacarbazina Medac
- Romania · Dacarbazina Lipomed
- Sweden · Dacarbazine Medac
- Slovakia · Dakarbazín Medac
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8bab94b8-a502-41d5-adc5-2b92a0491655 GET /v1/drugs/8bab94b8-a502-41d5-adc5-2b92a0491655?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "7323411000001109",
"desc": "Dacarbazine 100mg powder for solution for injection vials (medac UK)",
"form": "Powder for solution for injection",
"vpid": "7322711000001106",
"source": "dmd",
"vtm_id": "775433001",
"strength": "100 mg",
"substance": "Dacarbazine",
"ingredient": "Dacarbazine citrate",
"supplier_code": "9241811000001108"
}See everything about dacarbazine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.